New Jersey, United States - In a recently published report by Verified Market Research, titled,
Shares of Ardmore Shipping Co. (NYSE:ASC - Get Rating) have earned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and five have given a buy re
StockNews.com initiated coverage on Enzo Biochem in a research report on Wednesday. They issued a “hold” rating for the company.
Community Health Systems (NYSE:CYH) will be releasing earnings after the market closes on Wednesday, October 26, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=317247)
Learn more about the four firms shortlisted for our Editors’ Choice Award for Outstanding Fixed Income Trading Venue this year: Bloomberg MTF, LedgerEdge, MarketAxess’ Open Trading and Tradeweb.
Churchill Downs (NASDAQ:CHDN) will be releasing earnings after the market closes on Wednesday, October 26, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=347865)
Panellists at this week’s Digital Assets Summit explored the definition of a crypto versus traditional prime brokerage – and what role they can really play in the new world of digital assets investment.
Voyager Therapeutics, Inc. saw a sizeable drop in the number of short positions taken on the company during September (NASDAQ:
According to the report published by Allied Market Research, the global stockbroking market generated $38.5 billion in 2021, and is projected to reach $112.7
The market growth for algorithmic trading is significantly influenced by the financial services industry’s broad adoption of AI, ML, and big data.
indie Semiconductor, Inc. (NASDAQ:INDI - Get Rating) COO Steven Machuga sold 55,000 shares of the business’s stock in a transaction that occurred on Friday, October 14th. The stock was sold at an average price of $6.84, for a total value of $376,200.00. Following the transaction, the chief operating…
ADMA Biologics, Inc. (NASDAQ:ADMA - Get Rating) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 27,560,000 shares, a growth of 6.0% from the September 15th total of 25,990,000 shares. Based on an average daily volume of…
Adaptimmune Therapeutics plc (NASDAQ:ADAP - Get Rating) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 3,970,000 shares, an increase of 7.0% from the September 15th total of 3,710,000 shares. Approximately 2.8% of th…
American Resources Co. (NASDAQ:AREC - Get Rating) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 2,790,000 shares, an increase of 17.2% from the September 15th total of 2,380,000 shares. Approximately 5.1% of the…
Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Rating) was the recipient of a large increase in short interest in September. As of September 30th, there was short interest totalling 525,400 shares, an increase of 15.0% from the September 15th total of 457,000 shares. Based on an average trading volume…
Cellectis S.A. (NASDAQ:CLLS - Get Rating) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 722,600 shares, a decline of 11.8% from the September 15th total of 819,400 shares. Currently, 1.6% of the company…
During September, there was a noticeable increase in the number of people selling their Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI-Get
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Rating) was the recipient of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 993,400 shares, a decrease of 19.2% from the September 15th total of 1,230,000 shares. Approximatel…
Aurora Mobile Limited (NASDAQ:JG - Get Rating) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 284,900 shares, a decrease of 30.7% from the September 15th total of 411,100 shares. Currently, 0.4% of the company’s stock a…
BriaCell Therapeutics Corp. (NASDAQ:BCTX - Get Rating) saw a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 1,330,000 shares, a decline of 16.9% from the September 15th total of 1,600,000 shares. Currently, 12.8% of the comp…